Scholarlink

Background <p>Post-operative sore throat (POST) frequently complicates general anesthesia involving endotracheal intubation, affecting roughly 60% of individuals and markedly hindering postoperative recovery. The current systematic review and meta-analysis assessed both the safety profile and prophylactic efficacy of preoperative magnesium sulfate administered via nebulization against POST.</p> Methods <p>A systematic review and meta-analysis of randomized controlled trials (RCTs) comparing preoperative nebulized magnesium sulfate with placebo or normal saline for POST prevention in adults undergoing elective surgery under general anesthesia was conducted. The primary outcome was POST incidence at 24&#xa0;h. Secondary outcomes included POST at 2, 4, 8, and 12&#xa0;h, hoarseness, cough, and hemodynamic adverse events. PROSPERO registration: CRD420261308633.</p> Results <p>Twelve RCTs comprising 1,023 patients were included. Nebulized Magnesium Sulfate significantly reduced POST at 24&#xa0;h compared to control (RR = 0.25; 95% CI: 0.14–0.42; <i>p</i> &lt; 0.00001; I² = 62%). Sensitivity analysis excluding an outlier reduced heterogeneity (I² = 7%) while maintaining significance. Significant reductions were also observed at 2&#xa0;h (RR = 0.43; 95% CI: 0.32–0.58), 4&#xa0;h (RR = 0.38; 95% CI: 0.19–0.77), and 12&#xa0;h (RR = 0.34; 95% CI: 0.14–0.79). Subgroup analysis demonstrated comparable efficacy between the 225&#xa0;mg dose and higher doses, with no statistically significant difference observed. No significant reduction was observed for hoarseness (RR = 0.44; 95% CI: 0.17–1.18) or cough (RR = 0.39; 95% CI: 0.15–1.04), and no increased hemodynamic risk was detected. Trial sequential analysis confirmed robust evidence for POST prevention.</p> Conclusion <p>The administration of preoperative nebulized magnesium sulfate serves as an effective and safe measure to decrease POST incidence among adult patients, thereby justifying its inclusion in standard perioperative management protocols.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Nebulized magnesium sulfate reduces postoperative sore throat following general anesthesia: a systematic review, meta-analysis, and trial sequential analysis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月6日

查看全文
  • Sandara Bashir,
  • Muhammad Mustafa Khan,
  • Muhammad Hamad Khan,
  • Abdul Haseeb,
  • Abdullah Abdullah,
  • Abdul Saboor,
  • Habib Ur Rehman,
  • Rayaan Jan,
  • Aman Ullah,
  • Hassan Khalil,
  • Sayed Shahabuddin,
  • Abdul Muiz,
  • Yahya Samadi,
  • Asiya Shahzad

摘要

Background

Post-operative sore throat (POST) frequently complicates general anesthesia involving endotracheal intubation, affecting roughly 60% of individuals and markedly hindering postoperative recovery. The current systematic review and meta-analysis assessed both the safety profile and prophylactic efficacy of preoperative magnesium sulfate administered via nebulization against POST.

Methods

A systematic review and meta-analysis of randomized controlled trials (RCTs) comparing preoperative nebulized magnesium sulfate with placebo or normal saline for POST prevention in adults undergoing elective surgery under general anesthesia was conducted. The primary outcome was POST incidence at 24 h. Secondary outcomes included POST at 2, 4, 8, and 12 h, hoarseness, cough, and hemodynamic adverse events. PROSPERO registration: CRD420261308633.

Results

Twelve RCTs comprising 1,023 patients were included. Nebulized Magnesium Sulfate significantly reduced POST at 24 h compared to control (RR = 0.25; 95% CI: 0.14–0.42; p < 0.00001; I² = 62%). Sensitivity analysis excluding an outlier reduced heterogeneity (I² = 7%) while maintaining significance. Significant reductions were also observed at 2 h (RR = 0.43; 95% CI: 0.32–0.58), 4 h (RR = 0.38; 95% CI: 0.19–0.77), and 12 h (RR = 0.34; 95% CI: 0.14–0.79). Subgroup analysis demonstrated comparable efficacy between the 225 mg dose and higher doses, with no statistically significant difference observed. No significant reduction was observed for hoarseness (RR = 0.44; 95% CI: 0.17–1.18) or cough (RR = 0.39; 95% CI: 0.15–1.04), and no increased hemodynamic risk was detected. Trial sequential analysis confirmed robust evidence for POST prevention.

Conclusion

The administration of preoperative nebulized magnesium sulfate serves as an effective and safe measure to decrease POST incidence among adult patients, thereby justifying its inclusion in standard perioperative management protocols.